Tech Company Financing Transactions

VentiRx Pharmaceuticals Funding Round

Arch Venture Partners, Domain Associates and Frazier Healthcare Partners participated in a $6.3 million venture round for VentiRx Pharmaceuticals. The round was announced on 3/31/2012.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1191 Second Ave. 1105
Seattle, WA 98101
USA

Phone

(206) 689-2259

Website

www.ventirx.com

Email Address

[email protected]

Overview

VentiRx Pharmaceuticals, Inc. is a biopharmaceutical company committed to the development of novel medicines for the treatment of cancer, infectious, respiratory, and autoimmune diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Robert Hershberg

        

Chief Medical Officer

James Bryan

        

Chief Operating Officer

Kathleen Fanning

        

VP - Finance

Tom Swallow

        

VP - R & D

Gregory Dietsch

        

VP - Regulatory Affairs

Tressa Randall

        

Browse more venture capital transactions:

Prev: 3/31/2012: Swirl Networks venture capital transaction
Next: 3/31/2012: SenSage venture capital transaction

Share this article

Where The Data Comes From

We report on funding rounds that are announced publicly. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary